Concepedia

W. D. Bechtel

WD

Statistics

Publications

6

Citations

80

H-Index

6

Active since

1986

Affiliations

Boehringer Ingelheim (Germany)(Current)

W. D. Bechtel is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and neuropharmacology.

Publications per year

1986–1999

6

Publications

6

BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.

Thomas Weiser, Michael Brenner, Rainer Palluk et al. · PubMed · 1999 · 21 citations

, , +16

New tetracyclic guanidine derivatives with H1-antihistaminic properties. Chemistry of epinastine.

Guillaume Walther, Heide‐Marie Daniel, W. D. Bechtel et al. · PubMed · 1990 · 16 citations

, , +13

WAL 2014 FU (talsaclidine): A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease

Helmut A. Ensinger, W. D. Bechtel, F.W. Birke et al. · Drug Development Research · 1997 · 13 citations

, , +17

BIII 277 CL is a potent and specific ion-channel blocker of the NMDA receptor-channel complex.

A J Carter, W. D. Bechtel, Matthias Grauert et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 10 citations

, , +17

Biochemical pharmacology of pirenzepine. Similarities with tricyclic antidepressants in antimuscarinic effects only.

W. D. Bechtel, Joachim Mierau, Helmut Pelzer · PubMed · 1986 · 10 citations

, , +15

1–5 of 6